The Fedoruk Centre focuses on advancing nuclear science for medical health and environmental sustainability, primarily in Saskatchewan and worldwide. It produces radiopharmaceuticals such as FDG for nuclear imaging and provides funding for nuclear technology innovations.

The Fedoruk Centre

PanTera aims to secure the large-scale production of actinium-225 (Ac-225), targeting its use in radiopharmaceuticals for personalized cancer treatment. The company focuses on improving the accessibility of innovative cancer therapies based on Ac-225.

PanTera

Sylvia Fedoruk Canadian Centre for Nuclear Innovation | 279 followers on LinkedIn. We are welcoming you at 11th International Conference on Isotopes (11ICI) on July 23-27, 2023 | The purpose of the Sylvia Fedoruk Canadian Centre for Nuclear Innovation (the Fedoruk Centre) is to place Saskatchewan among global leaders in nuclear research, development and training through investment in partnerships with academia and industry for maximum societal and economic benefit.

The Fedoruk Centre supports research and education in nuclear medicine, social and environmental sciences related to nuclear technology development, nuclear energy and safety including small reactors, and materials research using nuclear techniques.

The Fedoruk Centre also operates the Saskatchewan Centre for Cyclotron Sciences as a research and educational tool for nuclear medicine, molecular imaging, and the supply of medical radioisotopes and radiopharmaceuticals.

Professor Emeritus of Engineering and Applied Science at the University of Regina (Retired Dean) and Professor Emeritus, Mechanical Engineering…

Esam Hussein

Facility General Manager at Sylvia Fedoruk Canadian Centre for Nuclear Innovation

Dale Schick-Martin, M.Sc.

Production Technologist at Canadian Center for nuclear innovation

Kalum Jayawardhana

Operations Technologist at The Fedoruk Centre's TR-24 Cyclotron

Logan Regier

Sylvia Fedoruk Canadian Centre for Nuclear Innovation

It was a pleasure for Fedoruk Centre Executive Director, John Root, to attend the Westinghouse Electric Company Supplier Symposium in Saskatoon last night. The event offered a fantastic opportunity to reconnect with familiar faces in the growing Saskatchewan nuclear community, while also making new industry contacts. We were especially excited to hear updates about Westinghouse’s eVinci micro modular reactor, their other products and their interests to engage with partners from industry, government and academia. It’s an exciting time for the #nuclear sector, and it’s inspiring to see opportunities for Saskatchewan to be placed among global leaders of nuclear research, development and training.

The Sylvia Fedoruk Canadian Centre for Nuclear Innovation is working to place the province of Saskatchewan, Canada, among global leaders in nuclear research, development, and training. 𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐭𝐡𝐞 𝐅𝐞𝐝𝐨𝐫𝐮𝐤 𝐂𝐞𝐧𝐭𝐫𝐞 𝐝𝐨? The Sylvia Fedoruk Canadian Centre for Nuclear Innovation partners with Saskatchewan universities to create academic leaders through four Fedoruk Chairs and funds research projects to drive nuclear innovation and provide hands-on student training. The Fedoruk Centre's Saskatchewan Cyclotron Facility produces radiopharmaceuticals, including FDG for PET-CT cancer scans, supporting over 3,000 patients annually. It also supports nuclear research and innovation for academia and industry. Learn more here: https://bit.ly/3ZSUc0I #NuclearResearch #NuclearEnergy #NuclearInnovation

Innovation News Network

“We’re making sure Saskatchewan has the capacity and resources to be at the forefront of nuclear innovation.” The Sylvia Fedoruk Canadian Centre for Nuclear Innovation and its operation of the Saskatchewan Cyclotron Facility at University of Saskatchewan is helping to place Saskatchewan among the leaders of nuclear innovation in medicine, technology and energy. Recently, the Fedoruk Centre has raised Saskatchewan's nuclear innovation profile globally with three major announcements, including an agreement with Canadian Nuclear Laboratories to increase global supply of Actinium-225, a rare medical isotope and groundbreaking weapon in the fight against cancer, and funding from Prairies Economic Development Canada I Développement économique Canada pour les Prairies that allows it to develop a new capacity to produce isotope Gallim-68 on demand for imaging specific cancers. These new opportunities will help Fedoruk Centre further invest in nuclear innovation in Saskatchewan, including its future in cleaner energy, and help alleviate human anxiety and suffering globally. Read more about the incredible work happening at Fedoruk Centre. https://ow.ly/zfr550QaNFp #nuclear #cancer #Saskatchewan #cleanenergy Government of Saskatchewan

Metric
Company Name	The Fedoruk Centre	PanTera
Symbol
MSH ID	CA:FEDORUKCENTRE	COM:PANTERA-LIFE
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Nuclear Technology	Biotechnology
Country	CA	BE
Stage
Employee Count
Website	fedorukcentre.ca	pantera-life.com
LinkedIn	sylvia-fedoruk-canadian-centre-for-nuclear-innovation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		3.34K
Web Traffic Growth		0.82
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

FEDO

CA:FEDORUKCENTRE

The Fedoruk Centre

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue